- Home
- RPTX vs CCEL Comparison
RPTX vs CCEL Comparison
Compare RPTX & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- CCEL
- Stock Information
- Founded
- RPTX 2016
- CCEL 1989
- Country
- RPTX Canada
- CCEL United States
- Employees
- RPTX N/A
- CCEL N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- CCEL Managed Health Care
- Sector
- RPTX Health Care
- CCEL Health Care
- Exchange
- RPTX Nasdaq
- CCEL Nasdaq
- Market Cap
- RPTX 53.2M
- CCEL 56.8M
- IPO Year
- RPTX 2020
- CCEL 1997
- Fundamental
- Price
- RPTX $1.12
- CCEL $6.49
- Analyst Decision
- RPTX Strong Buy
- CCEL Strong Buy
- Analyst Count
- RPTX 3
- CCEL 1
- Target Price
- RPTX $4.50
- CCEL $8.50
- AVG Volume (30 Days)
- RPTX 185.4K
- CCEL 16.0K
- Earning Date
- RPTX 03-03-2025
- CCEL 04-14-2025
- Dividend Yield
- RPTX N/A
- CCEL 3.92%
- EPS Growth
- RPTX N/A
- CCEL N/A
- EPS
- RPTX N/A
- CCEL 0.05
- Revenue
- RPTX $53,477,000.00
- CCEL $31,986,106.00
- Revenue This Year
- RPTX N/A
- CCEL $2.21
- Revenue Next Year
- RPTX $7.11
- CCEL $0.98
- P/E Ratio
- RPTX N/A
- CCEL $129.11
- Revenue Growth
- RPTX 4.58
- CCEL 2.05
- 52 Week Low
- RPTX $1.06
- CCEL $5.35
- 52 Week High
- RPTX $5.66
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- RPTX 36.62
- CCEL 38.48
- Support Level
- RPTX $1.12
- CCEL $6.27
- Resistance Level
- RPTX $1.25
- CCEL $6.97
- Average True Range (ATR)
- RPTX 0.09
- CCEL 0.62
- MACD
- RPTX -0.00
- CCEL -0.11
- Stochastic Oscillator
- RPTX 22.64
- CCEL 12.61
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.